6 unknown. 6 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Unknown 6 |
| Phase 2 | 1 | Unknown 1 |
Follow Urinary Bladder, Overactive: new trials by email Literature Review of Urinary Bladder, Overactive trials Research Report on Urinary Bladder, Overactive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of Oral Boldo in Women With Overactive Bladder Oxybutynin Pill, Boldo supplement - Urinary Bladder, Overactive | Phase 1 | Unknown | Universidad de Valparaiso | 10 | 2023-11-01 | 2023-12-08 |
| Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children Beta3-Agonists, Adrenergic, Anticholinergic drug, Solifenacin - Voiding Disorders, Overactive Bladder | Phase 1 / Phase 2 | Unknown | Mansoura University | 70 | 2022-02-01 | 2022-02-15 |
| Acupuncture Combined With Mirabegron in the Treatment of OAB 50 mg of mirabegron, acupuncture combined with mirabegron. - Overactive Bladder | Phase 1 | Unknown | The Affiliated Ganzhou Hospital of Nanchang University | 75 | 2021-12-01 | 2023-12-26 |
| A Study to Compare the Efficacy and Safety of Ultrasound Guided Lead Implantation for Sacral Neuromodulation (SNM) in Subjects With Overactive Bladder (OAB) With X-Ray Guided Technique ultrasound, X-ray - Refractory Overactive Bladder | Phase 1 | Unknown | Beijing Pins Medical Co., Ltd | 30 | 2017-02-01 | 2016-10-27 |
| A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects DA-8010, Placebo - Overactive Bladder | Phase 1 | Unknown | Dong-A ST Co., Ltd. | 110 | 2016-06-01 | 2016-07-01 |
| A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder Propantheline Bromide, Placebo - Overactive Bladder Associated With HTLV-1 | Phase 1 | Unknown | Hospital Universitário Professor Edgard Santos | 42 | 2012-05-01 | 2012-07-13 |
Nocturia (1)
Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Lower Urinary Tract Symptoms (6) · Male Urogenital Diseases (6) · Pathological Conditions, Signs and Symptoms (6) · Signs and Symptoms (6) · Urinary Bladder Diseases (6) · Urogenital Diseases (6) · Urologic Diseases (6) · Urological Manifestations (6)
Adrenergic beta-3 Receptor Agonists (1) · Cholinergic Antagonists (1) · DA-8010 (1) · High-Energy Shock Waves (1) · Propantheline (1) · Solifenacin Succinate (1) · X-Rays (1) · mirabegron (1) · oxybutynin (1)
Beijing Pins Medical Co., Ltd (1) · Dong-A ST Co., Ltd. (1) · Hospital Universitário Professor Edgard Santos (1) · Mansoura University (1) · The Affiliated Ganzhou Hospital of Nanchang University (1) · Universidad de Valparaiso (1)
Brazil (1) · Chile (1) · China (1)
Islam Mansour, Mb ChB (1) · Jisu Song (1) · Xiaolin Deng, M.D. (1)